MYOZYME subst sèche 50 mg flac
7680580380018
CH-58038
A16AB07
07.14.0.
Reimbursement limitations:
MYOZYME3
Evaluation pour commencer la thérapie avec Myozyme:
Le traitement avec Myozyme de patients atteints d’une …
1 / 2
google
Details
- Product number
- 5803801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: alglucosidasum alfa 50 mg, mannitolum, polysorbatum 80, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, pro vitro, natrium 6.56 mg.
Articles (1)
Myozyme, Poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
6.56 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 514.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2011
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 58038
- Drug name
- Myozyme, Poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- A16AB07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/05/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MYOZYME subst sèche 50 mg flac
- Description (DE)
- MYOZYME Trockensub 50 mg Durchstf
- Market launch
- 22/05/2008
- Narcotic (BTM)
- No